Dr Genghis Lopez
Senior Scientist
Adjunct Senior Lecturer, University of the Sunshine Coast
Connect with Dr Lopez
Genghis’ research interest includes the discovery and reporting of novel blood group antigens and complex red blood cell phenotypes. He investigates blood group incompatibilities associated with haemolytic transfusion reaction and haemolytic disease of the fetus and newborn. He is also interested in the distribution of clinically significant red cell and platelet antigens in different population groups.
Genghis received his PhD from Griffith University examining blood group gene variants and their contribution to blood group diversity.
Awards
- ANZSBT Travel Grant (2023)
- AIMS Research Engagement Grant Scheme (2020)
Leadership
- ISBT Working Party for Red Cell Immunogenetics and Blood Group Terminology (2024-present)
- Organising Committee, Queensland Immunohaematology Discussion Group (QIDG)
- Member of International Society of Blood Transfusion (ISBT)
- Member of Australia & New Zealand Society of Blood Transfusion (ANZSBT)
- Member of Australian Institute of Medical and Clinical Scientists (AIMS)
- Member of AABB
- Supervisor of PhD and Honours students
- Reviewer for Blood Advances, British Journal of Haematology, Scientific Reports Transfusion, Transfusion, and Vox Sanguinis
Key Publications
Impact of transcription factors KLF1 and GATA1 on red blood cell antigen expression: a review.
2024
Immunohematology
40(1):1-9
Feasibility for non‐invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell, platelet and quality control markers
2024
Br J Haematol
204: 694-705
A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D– Phenotypes Despite Normal RHD Exons.
2024
Transfusion Medicine and Hemotherapy
51(4):252-264
A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.
2024
Transfusion
64(6):1171-1176
Recurrent pregnancy loss in a patient with anti‐Rh17.
2024
Transfusion Medicine
34(1):66-70
